High resolution mapping of the binding site on human IgG1 for Fc gamma RI, Fc gamma RII, Fc gamma RIII, and FcRn and design of IgG1 variants with improved binding to the Fc gamma R - PubMed (original) (raw)
. 2001 Mar 2;276(9):6591-604.
doi: 10.1074/jbc.M009483200. Epub 2000 Nov 28.
A K Namenuk, K Hong, Y G Meng, J Rae, J Briggs, D Xie, J Lai, A Stadlen, B Li, J A Fox, L G Presta
Affiliations
- PMID: 11096108
- DOI: 10.1074/jbc.M009483200
Free article
High resolution mapping of the binding site on human IgG1 for Fc gamma RI, Fc gamma RII, Fc gamma RIII, and FcRn and design of IgG1 variants with improved binding to the Fc gamma R
R L Shields et al. J Biol Chem. 2001.
Free article
Abstract
Immunoglobulin G (IgG) Fc receptors play a critical role in linking IgG antibody-mediated immune responses with cellular effector functions. A high resolution map of the binding site on human IgG1 for human Fc gamma RI, Fc gamma RIIA, Fc gamma RIIB, Fc gamma RIIIA, and FcRn receptors has been determined. A common set of IgG1 residues is involved in binding to all Fc gamma R; Fc gamma RII and Fc gamma RIII also utilize residues outside this common set. In addition to residues which, when altered, abrogated binding to one or more of the receptors, several residues were found that improved binding only to specific receptors or simultaneously improved binding to one type of receptor and reduced binding to another type. Select IgG1 variants with improved binding to Fc gamma RIIIA exhibited up to 100% enhancement in antibody-dependent cell cytotoxicity using human effector cells; these variants included changes at residues not found at the binding interface in the IgG/Fc gamma RIIIA co-crystal structure (Sondermann, P., Huber, R., Oosthuizen, V., and Jacob, U. (2000) Nature 406, 267-273). These engineered antibodies may have important implications for improving antibody therapeutic efficacy.
Similar articles
- Engineering therapeutic antibodies for improved function.
Presta LG, Shields RL, Namenuk AK, Hong K, Meng YG. Presta LG, et al. Biochem Soc Trans. 2002 Aug;30(4):487-90. doi: 10.1042/bst0300487. Biochem Soc Trans. 2002. PMID: 12196120 Review. - Role of oligosaccharide residues of IgG1-Fc in Fc gamma RIIb binding.
Mimura Y, Sondermann P, Ghirlando R, Lund J, Young SP, Goodall M, Jefferis R. Mimura Y, et al. J Biol Chem. 2001 Dec 7;276(49):45539-47. doi: 10.1074/jbc.M107478200. Epub 2001 Sep 20. J Biol Chem. 2001. PMID: 11567028 - The N-linked oligosaccharide at Fc gamma RIIIa Asn-45: an inhibitory element for high Fc gamma RIIIa binding affinity to IgG glycoforms lacking core fucosylation.
Shibata-Koyama M, Iida S, Okazaki A, Mori K, Kitajima-Miyama K, Saitou S, Kakita S, Kanda Y, Shitara K, Kato K, Satoh M. Shibata-Koyama M, et al. Glycobiology. 2009 Feb;19(2):126-34. doi: 10.1093/glycob/cwn110. Epub 2008 Oct 24. Glycobiology. 2009. PMID: 18952826 Free PMC article. - IgG-Fc receptors and the clinical relevance of their polymorphisms.
de Haas M. de Haas M. Wien Klin Wochenschr. 2001 Oct 30;113(20-21):825-31. Wien Klin Wochenschr. 2001. PMID: 11732118 Review.
Cited by
- Cross-species analysis of Fc engineered anti-Lewis-Y human IgG1 variants in human neonatal receptor transgenic mice reveal importance of S254 and Y436 in binding human neonatal Fc receptor.
Burvenich IJ, Farrugia W, Lee FT, Catimel B, Liu Z, Makris D, Cao D, O'Keefe GJ, Brechbiel MW, King D, Spirkoska V, Allan LC, Ramsland PA, Scott AM. Burvenich IJ, et al. MAbs. 2016 May-Jun;8(4):775-86. doi: 10.1080/19420862.2016.1156285. Epub 2016 Mar 30. MAbs. 2016. PMID: 27030023 Free PMC article. - Intravenous immunoglobulin therapy: how does IgG modulate the immune system?
Schwab I, Nimmerjahn F. Schwab I, et al. Nat Rev Immunol. 2013 Mar;13(3):176-89. doi: 10.1038/nri3401. Epub 2013 Feb 15. Nat Rev Immunol. 2013. PMID: 23411799 Review. - Engineering hydrophobic protein-carbohydrate interactions to fine-tune monoclonal antibodies.
Yu X, Baruah K, Harvey DJ, Vasiljevic S, Alonzi DS, Song BD, Higgins MK, Bowden TA, Scanlan CN, Crispin M. Yu X, et al. J Am Chem Soc. 2013 Jul 3;135(26):9723-32. doi: 10.1021/ja4014375. Epub 2013 Jun 25. J Am Chem Soc. 2013. PMID: 23745692 Free PMC article. - Evolutionarily conserved paired immunoglobulin-like receptor α (PILRα) domain mediates its interaction with diverse sialylated ligands.
Sun Y, Senger K, Baginski TK, Mazloom A, Chinn Y, Pantua H, Hamidzadeh K, Ramani SR, Luis E, Tom I, Sebrell A, Quinones G, Ma Y, Mukhyala K, Sai T, Ding J, Haley B, Shadnia H, Kapadia SB, Gonzalez LC, Hass PE, Zarrin AA. Sun Y, et al. J Biol Chem. 2012 May 4;287(19):15837-50. doi: 10.1074/jbc.M111.286633. Epub 2012 Mar 6. J Biol Chem. 2012. PMID: 22396535 Free PMC article. - Glycovariant anti-CD37 monospecific protein therapeutic exhibits enhanced effector cell-mediated cytotoxicity against chronic and acute B cell malignancies.
Rafiq S, Siadak A, Butchar JP, Cheney C, Lozanski G, Jacob NK, Lapalombella R, McGourty J, Moledor M, Lowe R, Setter B, Jones J, Flynn JM, Andritsos L, Devine S, Mo X, Jarjoura D, Tridandapani S, Algate P, Byrd JC, Muthusamy N. Rafiq S, et al. MAbs. 2013 Sep-Oct;5(5):723-35. doi: 10.4161/mabs.25282. Epub 2013 Jun 7. MAbs. 2013. PMID: 23883821 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources